This included genetic testing, cloning and other aspects of molecular medicine.
The Commission was created after a review of the UK government biotechnology advisory framework in 1999.
From 2009, the Commission was chaired by Professor Jonathan Montgomery and comprised 21 members whose backgrounds include the law, medicine, consumer affairs, philosophy and ethics, scientific research, and clinical practice.
Representatives of the Chief Medical Officers of England, Scotland, Wales, and Northern Ireland also sat on the Commission.
[1][2] The Commission was abolished when quangos were reviewed by the newly elected government in October 2010.